ID

36807

Descripción

Treating Bacterial Overgrowth in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02470780

Link

https://clinicaltrials.gov/show/NCT02470780

Palabras clave

Versiones (1)
  1. 11/6/19 11/6/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

11 de junio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Parkinson's Disease NCT02470780

Inglés

Eligibility Parkinson's Disease NCT02470780

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of idiopathic pd
Descripción

Parkinson Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030567
daily "off" time ≥ 4 hours
Descripción

Off Treatment hours/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1518544
UMLS CUI [1,2]
C0556974
no changes in levodopa or any other dopaminergic medications expected during the course of the study
Descripción

Levodopa unchanged | Dopamine Agonists unchanged

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023570
UMLS CUI [1,2]
C0442739
UMLS CUI [2,1]
C0178601
UMLS CUI [2,2]
C0442739
will be screened for cognitive ability (montreal cognitive assessment score of ≥ 24) prior to enrollment
Descripción

Cognitive ability Montreal cognitive assessment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392334
UMLS CUI [1,2]
C3496286
will be screened for presence of sibo prior to enrollment
Descripción

SIBO Screening

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2959722
UMLS CUI [1,2]
C0220908
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any comorbid non-pd-associated gastrointestinal (e.g., achlorhydria) or systemic diseases that may alter absorption or confound the study results
Descripción

Gastrointestinal Disease Changing Absorption | Gastrointestinal Disease Interferes with Research results | Absence Relationship Parkinson Disease | Achlorhydria | Systemic disease Changing Absorption | Systemic disease Interferes with Research results

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0392747
UMLS CUI [1,3]
C0237442
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0683954
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0439849
UMLS CUI [3,3]
C0030567
UMLS CUI [4]
C0001075
UMLS CUI [5,1]
C0442893
UMLS CUI [5,2]
C0392747
UMLS CUI [5,3]
C0237442
UMLS CUI [6,1]
C0442893
UMLS CUI [6,2]
C0521102
UMLS CUI [6,3]
C0683954
exposure to proton pump inhibitors, immunosuppressive drugs, medications that affect gi motility (such as prokinetics, anticholinergics, and tricyclic antidepressants), antibiotics or any other drugs that affect the intestinal flora (such as laxatives) within a month prior to enrollment.
Descripción

Exposure to Proton Pump Inhibitors | Exposure to Immunosuppressive Agents | Pharmaceutical Preparations Affecting Gastrointestinal Motility | Prokinetic Agent | Anticholinergic Agents | Tricyclic Antidepressive Agents | Antibiotics | Pharmaceutical Preparations Affecting Intestinal Flora | Laxatives

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0358591
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0021081
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0017184
UMLS CUI [4]
C1268865
UMLS CUI [5]
C0242896
UMLS CUI [6]
C0003290
UMLS CUI [7]
C0003232
UMLS CUI [8,1]
C0013227
UMLS CUI [8,2]
C0392760
UMLS CUI [8,3]
C2985398
UMLS CUI [9]
C0282090
prior deep brain stimulation or ablative functional neurosurgery.
Descripción

Deep Brain Stimulation | Ablation Neurosurgical Procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0394162
UMLS CUI [2,1]
C0547070
UMLS CUI [2,2]
C0524850
prior allergy to rifaximin
Descripción

Hypersensitivity Rifaximin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0073374
women who are pregnant, lactating, or plan to become pregnant.
Descripción

Pregnancy | Breast Feeding | Pregnancy, Planned

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
Volver a la parte superior de la página

Similar models

Eligibility Parkinson's Disease NCT02470780

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease
Item
diagnosis of idiopathic pd
boolean
C0030567 (UMLS CUI [1])
Off Treatment hours/day
Item
daily "off" time ≥ 4 hours
boolean
C1518544 (UMLS CUI [1,1])
C0556974 (UMLS CUI [1,2])
Levodopa unchanged | Dopamine Agonists unchanged
Item
no changes in levodopa or any other dopaminergic medications expected during the course of the study
boolean
C0023570 (UMLS CUI [1,1])
C0442739 (UMLS CUI [1,2])
C0178601 (UMLS CUI [2,1])
C0442739 (UMLS CUI [2,2])
Cognitive ability Montreal cognitive assessment
Item
will be screened for cognitive ability (montreal cognitive assessment score of ≥ 24) prior to enrollment
boolean
C0392334 (UMLS CUI [1,1])
C3496286 (UMLS CUI [1,2])
SIBO Screening
Item
will be screened for presence of sibo prior to enrollment
boolean
C2959722 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Gastrointestinal Disease Changing Absorption | Gastrointestinal Disease Interferes with Research results | Absence Relationship Parkinson Disease | Achlorhydria | Systemic disease Changing Absorption | Systemic disease Interferes with Research results
Item
any comorbid non-pd-associated gastrointestinal (e.g., achlorhydria) or systemic diseases that may alter absorption or confound the study results
boolean
C0017178 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
C0017178 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0683954 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0439849 (UMLS CUI [3,2])
C0030567 (UMLS CUI [3,3])
C0001075 (UMLS CUI [4])
C0442893 (UMLS CUI [5,1])
C0392747 (UMLS CUI [5,2])
C0237442 (UMLS CUI [5,3])
C0442893 (UMLS CUI [6,1])
C0521102 (UMLS CUI [6,2])
C0683954 (UMLS CUI [6,3])
Exposure to Proton Pump Inhibitors | Exposure to Immunosuppressive Agents | Pharmaceutical Preparations Affecting Gastrointestinal Motility | Prokinetic Agent | Anticholinergic Agents | Tricyclic Antidepressive Agents | Antibiotics | Pharmaceutical Preparations Affecting Intestinal Flora | Laxatives
Item
exposure to proton pump inhibitors, immunosuppressive drugs, medications that affect gi motility (such as prokinetics, anticholinergics, and tricyclic antidepressants), antibiotics or any other drugs that affect the intestinal flora (such as laxatives) within a month prior to enrollment.
boolean
C0332157 (UMLS CUI [1,1])
C0358591 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0021081 (UMLS CUI [2,2])
C0013227 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0017184 (UMLS CUI [3,3])
C1268865 (UMLS CUI [4])
C0242896 (UMLS CUI [5])
C0003290 (UMLS CUI [6])
C0003232 (UMLS CUI [7])
C0013227 (UMLS CUI [8,1])
C0392760 (UMLS CUI [8,2])
C2985398 (UMLS CUI [8,3])
C0282090 (UMLS CUI [9])
Deep Brain Stimulation | Ablation Neurosurgical Procedure
Item
prior deep brain stimulation or ablative functional neurosurgery.
boolean
C0394162 (UMLS CUI [1])
C0547070 (UMLS CUI [2,1])
C0524850 (UMLS CUI [2,2])
Hypersensitivity Rifaximin
Item
prior allergy to rifaximin
boolean
C0020517 (UMLS CUI [1,1])
C0073374 (UMLS CUI [1,2])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
women who are pregnant, lactating, or plan to become pregnant.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial